Domestic cats have long been fingered as voracious hunters, causing dozens of native-mammal extinctions in Australia alone. But the purring predators bring with them another threat to the wild, according to research published by Britain’s Royal Society: the spread of disease. Scientists at the University of British Columbia in Canada said the prevalence of toxoplasmosis, which can cause flu-like symptoms in humans and cysts in wild animals, can be traced to the world’s estimated 600 million housecats, with the incidence of disease rising among wild animals in regions where pet cats are common.
The “profound” impact of the coronavirus pandemic and related cuts to health care left more than 4.3 million more people suffering from tuberculosis (TB) without treatment in 2020, according to the Stop TB Partnership. Neglecting TB cases means “all but certain death for probably half that number,” the Partnership, a United Nations-linked body, said on Tuesday. Lucica Ditiu, executive director of the partnership, warned that the roughly 50 per cent of survivors “will not only suffer the consequences of the disease but will also spread TB to many more, perpetuating the cycle of transmission.” The prioritization of coronavirus has in turn meant 1.2 million fewer TB diagnoses so far this year compared to 2019.
DUBLIN — Coffee not only takes bleary out of bleary-eyed, according to British scientists, but lowers the likelihood of liver disease so long as it’s no more than three or four cups a day. Researchers at the University of Edinburgh and the University of Southampton looked at health data for almost half a million people and concluded that “drinking any type of coffee was associated with a reduced risk of developing and dying from chronic liver disease compared to not drinking coffee.” According to Oliver Kennedy, the lead author of the study, which was published by BioMedCentral, a Springer Nature journal, coffee “could offer a potential preventative treatment for chronic liver disease.”
DUBLIN — Some 1.7 billion people have at least one underlying health condition that “could increase their risk of severe Covid-19 if infected,” according to a British medical journal. Estimates published in The Lancet Global Health point to heightened risks from the coronavirus pandemic in regions with relatively high numbers of older people, such as Europe, and in regions with a higher prevalence of HIV/AIDS, such as Africa. Using data from 188 countries, the authors of the report estimate that 66 per cent of the world’s over-70s have an underlying condition – such as diabetes or cardiovascular disease – that could leave them vulnerable should they contract the new coronavirus. That percentage drops to 23 among working-age people, with only 5 per cent of under-20s estimated to have developed such a condition.
SINGAPORE – With “Western-style” ailments such as obesity and diabetes on the increase in Asia, health-related businesses are ramping up their efforts to keep those diseases at bay. Asia’s spending on health care has been soaring. By 2017, the region’s expenditure will reach $2.1 trillion, 24% of the global total, according to a report by The Economist Intelligence Unit. “As incomes rise, education levels also improve, creating much greater awareness of health issues,” the report said. But as Asians earn more, they are becoming not only better educated but also more susceptible to so-called “lifestyle” diseases — afflictions the World Health Organization classes as “noncommunicable” and “chronic.” Chronic maladies such as heart disease and diabetes are the No. 1 killers in Southeast Asia, accounting for 62% of all deaths, according to the WHO. Growing Asian affluence and the spread of fast-food chains have led to increasingly unhealthy eating habits, as foods high in fat, salt and sugar are consumed in greater amounts. This, in turn, has caused a spike in conditions previously more common in Western countries. Malaysia-based IHH Healthcare is among the hospital operators responding to the region’s growing medical needs. “Rapid growth, rapid rise in affluence and the development of the middle income group, these are all very favorable factors for the health care industry,” said Tan See Leng, IHH’s managing director and CEO, speaking at the FT-Nikkei Asia300 Forum in Hong Kong on April 25.